Ignite Creation Date:
2025-12-25 @ 5:08 AM
Ignite Modification Date:
2026-06-25 @ 1:25 AM
Study NCT ID:
NCT05925127
Status:
COMPLETED
Last Update Posted:
2024-12-13
First Post:
2023-06-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 2/3 Heterologous Boosting Study With Different Dose Levels of Monovalent SARS-CoV-2 rS Vaccines
Sponsor:
Novavax
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | COVID-19 | View |
Keywords: